Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
3 Nov 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaPhase 3 Study of HS-10380 for Acute Schizophrenia in Chinese AdultsPhase 3Not Yet Recruiting3 Nov 2026Jiangsu HengRui Medicine Co., Ltd.ChinaA Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal InsulinPhase 3Not Yet Recruiting3 Nov 2026Jiangsu Simcere Pharmaceutical Co., Ltd.ChinaStudy of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 1Not Yet Recruiting3 Nov 2026Mabwell (Shanghai) Bioscience Co., Ltd.ChinaPhase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood CancersPhase 1Recruiting3 Nov 2026Xintian PharmaceuticalChinaClinical Study on the Efficacy and Safety of Heyan® Kuntai Capsules in Alleviating Perimenopausal Symptoms Induced by GnRH-aPhase 4Completed2 Nov 2026Galderma R&DChinaA Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour DeficienciesNot applicableNot Yet Recruiting2 Nov 2026Guangzhou Patronus Biotech Co., Ltd.ChinaA Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderPhase 3Not Yet Recruiting2 Nov 2026Jiangsu Jingze Biopharmaceutical Co., Ltd.ChinaA Study Evaluating the Efficacy and Safety of Recombinant Human Truncated Plasmin Injection (JZB32) in Patients With Vitreomacular TractionPhase 2Recruiting2 Nov 2026Keymed Biosciences Co.LtdChinaStudy of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple MyelomaPhase 3Not Yet Recruiting2 Nov 2026Nanjing Chia-tai Tianqing PharmaceuticalChinaA Phase 1 Clinical Trial of NTQ6179 Tablets in Healthy VolunteersPhase 1Recruiting2 Nov 2026Peijia Medical Technology (Suzhou) Co., Ltd.ChinaTarget Value Study to Evaluate the Safety and Efficacy of the Taurus NXT® Transcatheter Aortic Valve System for the Treatment of Severe Calcific Aortic StenosisNot applicableActive Not Recruiting2 Nov 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaA Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary FibrosisPhase 2Not Yet Recruiting30 Oct 2026Shanghai Hengrui Pharmaceutical Co., Ltd.ChinaA Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy ParticipantsPhase 1Not Yet Recruiting30 Oct 2026Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdChinaA Mass Balance Study on [14C]Levornidazole Disodium Phosphate for Injection in Healthy Chinese Adult Male SubjectsPhase 1Completed30 Oct 2026Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdChinaPharmacokinetics and Safety of Levornidazole Disodium Phosphate for Injection in Chinese Patients With Hepatic ImpairmentPhase 1Completed29 Oct 2026AstraZenecaChinaClarify HPP: Disease Burden of HPP Patients in ChinaRecruiting29 Oct 2026Guizhou Sinorda Pharmaceutical Co., Ltd.ChinaSND002 Cell Injection in Participants With Advanced Malignant Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaA Study of IBI3043 Treatment in Participants With Locally Advanced, Unresectable or Metastatic Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaHB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial CancerPhase 3Recruiting29 Oct 2026Sinocelltech Ltd.ChinaPhase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis BPhase 1Not Yet Recruiting29 Oct 2026Vigonvita Life SciencesChinaA Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's DiseasePhase 2Not Yet Recruiting28 Oct 2026Anhui HygeianCells BioMedical Co., Ltd.ChinaA Single-Center Phase 1 Study of ceAF for Knee Osteoarthritis (KOA)Phase 1Recruiting28 Oct 2026Beijing InnoCare Pharma Tech Co., Ltd.ChinaEvaluation of ICP-B381 in Patients With Advanced Solid TumorsPhase 1, Phase 2Recruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting28 Oct 2026Keymed Biosciences Co.LtdChinaStudy of Single and Multiple Ascending Doses of CM551 in Healthy ParticipantsPhase 1Not Yet Recruiting28 Oct 2026Novo Nordisk A/SChinaA Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in ChinaPhase 4Recruiting28 Oct 2026Shanghai Hengrui Pharmaceutical Co., Ltd.ChinaHRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic CancerPhase 3Not Yet Recruiting28 Oct 2026Shanghai Huaota Biopharmaceutical Co., Ltd.ChinaA Study of HB0056 in Adult Participants With Moderate to Severe AsthmaPhase 1, Phase 2Recruiting28 Oct 2026Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.ChinaThis Study Will Evaluate the Effect and Safety of 626 in Patients With CLEPhase 2Not Yet Recruiting28 Oct 2026Wecare Probiotics Co., Ltd.ChinaDigestion and Absorption of Postbiotic Regulatory ProteinsNot applicableRecruiting27 Oct 2026Axter Therapeutics (Beijing) Co., LtdChinaAXT-1003 Combination With Enzalutamide in Participants With mCRPCPhase 1Recruiting27 Oct 2026Beijing InnoCare Pharma Tech Co., Ltd.ChinaOrelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone LymphomaPhase 3Not Yet Recruiting27 Oct 2026ChinaNormChinaMask Instant Clinical StudyNot applicableCompleted27 Oct 2026GuangZhou Cellgenes Biotechnology Co., Ltd.ChinaSafety and Efficacy of CG-BM1 in Ischemic StrokePhase 1, Phase 2Recruiting27 Oct 2026Jiangsu Aosaikang Pharmaceutical Co., Ltd.ChinaASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLCPhase 3Not Yet Recruiting27 Oct 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Study to Evaluate the Pharmacokinetic Characteristics of HS-20118 Under Different Dosing Conditions in Healthy ParticipantsPhase 1Active Not Recruiting27 Oct 2026Shaanxi Giant Biotechnology Co., LtdChinaRecombinant Collagen Freeze-Dried Fibre for Upper Facial WrinklesNot applicableCompleted27 Oct 2026Triastek, lnc.ChinaA Food-Effect Study of Budesonide Delayed Release Tablet (D23A) in Healthy Chinese ParticipantsPhase 1Not Yet Recruiting26 Oct 2026BYHEALTH Co., LTDChinaStudy on the Effects of Probiotic on Infant Gut Microbiota and Immune RegulationNot applicableCompleted26 Oct 2026Changchun BCHT Biotechnology Co.ChinaA Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Phase 2Recruiting26 Oct 2026ChinaNormChinaPre- and Post-procedure Skin Knowledge StudyNot applicableRecruiting26 Oct 2026Jiangsu HengRui Medicine Co., Ltd.ChinaA Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast CancerPhase 3Not Yet Recruiting26 Oct 2026Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.ChinaPhase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic DermatitisPhase 2Recruiting26 Oct 2026Nuwacell Biotechnologies Co., Ltd.ChinaA Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBSPhase 1Not Yet Recruiting26 Oct 2026RemeGen Co., Ltd.ChinaPhase II Clinical Study of RC148 (ABBV-1480) in Combination With Telisotuzumab Adizutecan (With or Without Chemotherapy) for Unresectable Colorectal CancerPhase 2Not Yet Recruiting26 Oct 2026Suzhou Suncadia Biopharmaceuticals Co., Ltd.ChinaSHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III StudyPhase 3Not Yet Recruiting26 Oct 2026Suzhou Suncadia Biopharmaceuticals Co., Ltd.ChinaA Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung CancerPhase 3Not Yet Recruiting26 Oct 2026Xiamen Amoytop Biotech Co., Ltd.ChinaA Clinical Study of Long-Term Administration of Inpegsomatropin Injection in Participants With Idiopathic Short Stature Who Have Completed Phase Ⅲ Clinical TrialsNot applicableRecruiting23 Oct 2026Galderma R&DChinaA Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™Recruiting23 Oct 2026GuangZhou Cellgenes Biotechnology Co., Ltd.ChinaClinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Acute Respiratory Distress SyndromePhase 1Completed// How AOS uses this